NO162192C - Analogifremgangsmaate for fremstilling av et terapeutisk aktivt beta-laktam-antibiotikum. - Google Patents

Analogifremgangsmaate for fremstilling av et terapeutisk aktivt beta-laktam-antibiotikum.

Info

Publication number
NO162192C
NO162192C NO822538A NO822538A NO162192C NO 162192 C NO162192 C NO 162192C NO 822538 A NO822538 A NO 822538A NO 822538 A NO822538 A NO 822538A NO 162192 C NO162192 C NO 162192C
Authority
NO
Norway
Prior art keywords
preparing
lactam antibiotic
therapeutic active
active beta
analogy procedure
Prior art date
Application number
NO822538A
Other languages
English (en)
Norwegian (no)
Other versions
NO822538L (no
NO162192B (no
Inventor
Peter Henry Milner
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of NO822538L publication Critical patent/NO822538L/no
Publication of NO162192B publication Critical patent/NO162192B/no
Publication of NO162192C publication Critical patent/NO162192C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/12—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NO822538A 1981-07-25 1982-07-23 Analogifremgangsmaate for fremstilling av et terapeutisk aktivt beta-laktam-antibiotikum. NO162192C (no)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB8123033 1981-07-25
GB8123034 1981-07-25
GB8136823 1981-12-07
GB8136824 1981-12-07
GB8207966 1982-03-18
GB8209954 1982-04-03
GB8209953 1982-04-03
GB8215007 1982-05-22

Publications (3)

Publication Number Publication Date
NO822538L NO822538L (no) 1983-01-26
NO162192B NO162192B (no) 1989-08-14
NO162192C true NO162192C (no) 1989-11-22

Family

ID=27571208

Family Applications (1)

Application Number Title Priority Date Filing Date
NO822538A NO162192C (no) 1981-07-25 1982-07-23 Analogifremgangsmaate for fremstilling av et terapeutisk aktivt beta-laktam-antibiotikum.

Country Status (18)

Country Link
US (3) US4539149A (cs)
EP (1) EP0071395B1 (cs)
KR (1) KR900000934B1 (cs)
AU (1) AU568062B2 (cs)
CA (1) CA1216576A (cs)
DE (1) DE3278878D1 (cs)
FI (1) FI78702C (cs)
GB (1) GB2107307B (cs)
GR (1) GR76544B (cs)
HK (1) HK58088A (cs)
KE (1) KE3810A (cs)
MY (1) MY8700744A (cs)
NO (1) NO162192C (cs)
NZ (1) NZ201369A (cs)
PH (4) PH20467A (cs)
PL (2) PL145252B1 (cs)
PT (1) PT75304B (cs)
YU (2) YU43083B (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4555363A (en) * 1983-01-21 1985-11-26 Beecham Group P.L.C. Process for the preparation of β-lactam compounds
GR79784B (cs) * 1983-01-21 1984-10-31 Beecham Group Plc
GB8301694D0 (en) * 1983-01-21 1983-02-23 Beecham Group Plc Beta-lactam antibacterial agents
DE3468027D1 (en) * 1983-01-21 1988-01-21 Beecham Group Plc Beta-lactam antibacterial agents
EP0114750A3 (en) * 1983-01-24 1985-07-31 Beecham Group Plc Beta-lactam antibacterial agents
EP0131174B1 (en) * 1983-07-07 1989-09-13 Beecham Group Plc Substituted phenylglycine derivatives of beta-lactam antibiotics
JPS6066987A (ja) * 1983-09-20 1985-04-17 Takeda Chem Ind Ltd 抗生物質ｔａν−５４７，その製造法および微生物
DE3481769D1 (de) * 1984-01-23 1990-05-03 Takeda Chemical Industries Ltd Cephemderivate und ihre herstellung.
EP0160745A3 (en) * 1984-05-07 1986-11-05 Takeda Chemical Industries, Ltd. Cephem compounds and their production
EP0167011A3 (en) * 1984-06-12 1986-03-19 Beecham Group Plc Beta-lactam compounds, intermediates thereof, their use in preparing beta-lactams having a diketopiperazine group
EP0168177A3 (en) * 1984-06-28 1987-04-01 Pfizer Limited Cephalosporin antibiotics
EP0219926A3 (en) * 1985-06-25 1988-08-31 Beecham Group Plc Cephalosporins, processes for their preparation and pharmaceutical compositions containing them
JPS6230789A (ja) * 1985-08-01 1987-02-09 Yamanouchi Pharmaceut Co Ltd ７−ホルミルアミノセフアロスポリン化合物およびその製造法
EP0211656A3 (en) * 1985-08-10 1988-03-09 Beecham Group Plc Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
GB8531202D0 (en) * 1985-12-18 1986-01-29 Pfizer Ltd Cephalosporin antibiotics
US4666835A (en) * 1986-04-29 1987-05-19 Baldwin Jack E 2-vinylpenams and process
GB8709666D0 (en) * 1987-04-23 1987-05-28 Beecham Group Plc Compounds
GB8719875D0 (en) * 1987-08-22 1987-09-30 Beecham Group Plc Compounds
GB8722477D0 (en) * 1987-09-24 1987-10-28 Beecham Group Plc Compounds
DE3733626A1 (de) * 1987-10-05 1989-04-13 Bayer Ag Heteroanellierte phenylglycin-(beta)-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69016719T2 (de) * 1989-09-04 1995-06-01 Beecham Group Plc Cephalosporinderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate und Zwischenverbindungen.
US7601864B1 (en) * 2008-05-08 2009-10-13 Ufc Corporation Method for synthesizing 4,4-dihalogen-2-(dialkylamino)methylene-3-oxy-alkylbutyrate and derivatives thereof
WO2013057196A1 (en) 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of cefamandole nafate
WO2013057197A1 (en) 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the formylation of cefamandole

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR205683A1 (es) * 1970-06-16 1976-05-31 Merck & Co Inc Procedimiento para la preparacion del ester de bencilo del acido 6-metoxi-6-acilamido penicilanico
GB1442302A (en) * 1972-07-21 1976-07-14 Glaxo Lab Ltd Penicillin and cephalosporin derivatives
US3868365A (en) * 1972-12-06 1975-02-25 Squibb & Sons Inc Method for preparing 6-substituted penicillins by replacement of oxygen containing groups
US4062842A (en) * 1973-09-06 1977-12-13 E. R. Squibb & Sons, Inc. Method for preparing 7-substituted cephalosporins and 6-substituted penicillins by replacement of sulfur-containing groups
US3937655A (en) * 1974-04-16 1976-02-10 Eli Lilly And Company Method for preparing stable β-lactam-type-antibiotic susceptibility test discs
US3962214A (en) * 1974-07-11 1976-06-08 Eli Lilly And Company Process for preparing amino substituted β-lactam antibiotics
US4281117A (en) * 1980-09-04 1981-07-28 Eli Lilly And Company Process for 3-chloro cephalosporin nucleus

Also Published As

Publication number Publication date
HK58088A (en) 1988-08-05
PH20467A (en) 1987-01-14
US4609652A (en) 1986-09-02
AU568062B2 (en) 1987-12-17
YU45671B (sh) 1992-07-20
YU43083B (en) 1989-02-28
YU178484A (en) 1987-12-31
MY8700744A (en) 1987-12-31
AU8635182A (en) 1984-10-18
GB2107307B (en) 1986-02-26
EP0071395A1 (en) 1983-02-09
NO822538L (no) 1983-01-26
NO162192B (no) 1989-08-14
NZ201369A (en) 1985-12-13
US4539149A (en) 1985-09-03
CA1216576A (en) 1987-01-13
EP0071395B1 (en) 1988-08-10
GR76544B (cs) 1984-08-10
PH21702A (en) 1988-01-27
KR900000934B1 (ko) 1990-02-19
FI822606L (fi) 1983-01-26
PL248815A1 (en) 1985-04-09
KE3810A (en) 1988-08-05
PH21703A (en) 1988-01-27
US4877783A (en) 1989-10-31
FI78702C (fi) 1989-09-11
KR840000559A (ko) 1984-02-25
FI78702B (fi) 1989-05-31
PT75304B (en) 1984-07-31
DE3278878D1 (en) 1988-09-15
YU162382A (en) 1985-04-30
PH21701A (en) 1988-01-27
PT75304A (en) 1982-08-01
PL146182B1 (en) 1989-01-31
PL237640A1 (en) 1985-01-02
PL145252B1 (en) 1988-08-31
GB2107307A (en) 1983-04-27
FI822606A0 (fi) 1982-07-23

Similar Documents

Publication Publication Date Title
NO162192C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt beta-laktam-antibiotikum.
NO160261C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse n-metyl-11-aza-10-deokso-10-dihydroerytromycin a.
NO164653C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt indol-derivat.
NO167572C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt purinderivat.
NO163691C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider.
NO161117C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO164301C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
FI882362A0 (fi) Foerfarande foer framstaellning av en tunn film foer supraledande oxider.
NO155496C (no) Fremgangsmaate for fremstilling av glykopeptidantibiotikum a/16686.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO167797C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt nitrometan.
NO163954C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt amidinderivat.
NO159591C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt karbostyrilderivat.
NO156263C (no) Innretning for retningsstyring av et prosjektil.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO163284B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenem-antibiotika.
NO852948L (no) Fremgangsmaate for fremstilling av et diisopropyleter-solvat av beclomethason-17,21-dipropionat.
NO158063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater.
NO156653C (no) Fremgangsmaate for fremstilling av et antibiotikum.
NO159798C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporin-oksyder.
NO164239C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt karbapenemderivat.
NO159658C (no) Mellomprodukt for fremstilling av 1,1-diokso-penicillanoyloksymetyl-6-(2-amino-2-fenyl-acetamido)penicillanat-antibiotika.
NO154965C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolderivater.